Cytokinetics, Incorporated
Cytokinetics, Incorporated scores highest on Torque (97) and lowest on Price (0). Its PosiPenta is 49.29 out of 100, around the middle of similar companies.
On the Penta Grid this week, Cytokinetics, Incorporated is Grid #297 of 837 in the Healthcare sector in United States, and Grid #1,958 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Cytokinetics, Incorporated | 49.29 | 0 | 30 | 61 | 97 | 59 |
| Spyre Therapeutics, Inc. | 45.10 | 10 | 21 | 78 | 76 | 40 |
| Bruker Corporation | 60.55 | 19 | 76 | 82 | 48 | 78 |
| ImmunityBio, Inc. | 64.03 | 0 | 61 | 80 | 96 | 83 |
| Hinge Health, Inc. | 62.78 | 22 | 56 | 94 | 82 | 60 |
| Caris Life Sciences, Inc. | 62.42 | 39 | 47 | 93 | 57 | 77 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -8.58 |
| P/B ratio | -49.64 |
EEarnings
| Trailing EPS | ₹-683.84 |
| Forward EPS | ₹-422.87 |
NNitro
| Price | 5867.59 |
| 52-week high | 8364.28 |
| 52-week low | 5143.02 |
| Fall from 52-week high | 29.8% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -1.95 |
AAnchor
| Beta (price swings) | 0.41 |
| Market cap | ₹81,573 Cr |
| Insider holding | 0.57% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Cytokinetics, Incorporated's PosiPenta score?
Cytokinetics, Incorporated's PosiPenta is 49.29 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Cytokinetics, Incorporated stand on the Penta Grid?
On the Penta Grid this week, Cytokinetics, Incorporated is Grid #297 of 837 in the Healthcare sector in United States, and Grid #1,958 of 4,000 in United States.
Which PosiPenta pillar is strongest for Cytokinetics, Incorporated?
Torque (durability), with a score of 97 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Cytokinetics, Incorporated?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Cytokinetics, Incorporated's PosiPenta changed since last week?
Yes, it rose 11.94 points, from 37.35 to 49.29.
PositoAI is for research and education only and is not investment advice.